Daymark Health Secures $20 Million to Expand Innovative Cancer Care Platform Nationwide

Daymark Health Secures $20 Million in Series A Funding

Daymark Health, a pioneer in innovative cancer care solutions, has successfully raised $20 million in a Series A funding round led by Healthier Capital, alongside contributions from the Blue Venture Fund and other existing investors, such as Yosemite, Maverick Ventures, and Oncology Ventures. This financial boost is set to enhance Daymark's mission of transforming the cancer care journey for patients, healthcare providers, and health plans alike.

Redefining Cancer Care

Founded with the goal of revolutionizing the oncology experience, Daymark Health is dedicated to addressing the holistic needs of cancer patients. Through an integrated, tech-enabled platform, the company collaborates closely with oncologists and primary care providers to offer comprehensive support. This includes not only clinical care but also mental health resources and social assistance to ensure that patients receive well-rounded care tailored to their needs.

Daymark Health's approach is rooted in accessibility and personalization. By delivering care both within the home environment and through virtual channels, the company can reach a greater number of patients, providing them essential services like care navigation, continuous support, and symptom management. With this funding, Daymark aims to expand its reach to thousands of patients nationwide, making a significant impact on the oncology landscape.

A Growing Investment in Oncology

Dr. Justin Bekelman, CEO and Co-Founder of Daymark Health, recognizes that the oncology field is undergoing a critical transformation. As payers face mounting pressure to manage specialty risks, and providers increasingly seek patient-centric solutions, Daymark’s model stands out. "We are committed to offering intelligent and compassionate cancer care, and this investment will help us extend our services further," said Dr. Bekelman.

Healthier Capital, known for partnering with technology-driven innovators, plays a pivotal role in this investment. Founded by Amir Dan Rubin, the former CEO of One Medical, Healthier Capital aims to promote healthier outcomes throughout the healthcare system. The collaboration with the Blue Venture Fund—which comprises 36 Blue Cross and Blue Shield companies—highlights a united commitment to advance oncology care.

Collaborative Care Model

The investment from these funds signifies a broader trend in the healthcare industry where providers and payers alike recognize the necessity for integrated and sustainable care models. Dr. Aman Mahajan, Partner at Healthier Capital, commended Daymark for dismantling barriers in healthcare delivery, facilitating personalized experiences for cancer patients, and enhancing outcomes while reducing unnecessary costs.

Equally enthusiastic is Kelsey Maguire, Managing Director at Blue Venture Fund, who noted the alignment of purposes between Daymark and the fund to offer the best care possible, ensuring that every patient feels acknowledged and valued.

By integrating advanced technology with compassionate care practices, Daymark Health is poised to change how cancer support services are structured, making strides towards a future where patient needs come first.

The Future of Cancer Care

As Daymark Health prepares to scale its operations, the focus remains on innovative solutions. Patients can expect enhanced technology-driven services that cater to their clinical, emotional, and social health needs, all aimed at fostering an improved cancer care journey. With the increasing recognition of the need for personalized and efficient oncology care, Daymark is not just participating in this shift; it is leading the charge.

For additional details about Daymark Health and its initiatives, prospective patients and healthcare partners can visit their official website at www.daymarkhealth.com.

In summary, Daymark Health's recent funding represents a significant move toward reshaping cancer care. The company stands at a crucial crossroads, ready to harness its resources for wider outreach and better patient support. The commitment of new partners reflects an industry-wide recognition that the future of oncology is not just about treatment, but comprehensive, compassionate care that addresses all facets of a patient's journey.